SHINVA Debuts at CPHI 2026 in Bangkok Joining ASEAN to Build a New Global Pharmaceutical Industry Ecosystem
CPHI South East Asia 2026 made a grand opening at Queen Sirikit National Convention Center (QSNCC) Bangkok, Thailand during July 8–10, 2026. As a highly influential professional exhibition for pharmaceutical manufacturing in Southeast Asia, the event gathered over 400 global exhibitors and professional buyers from more than 70 countries to explore new cooperation opportunities covering APIs, finished formulations, pharmaceutical equipment, advanced technologies and supply chains.
As a leading Chinese enterprise in medical devices and pharmaceutical equipment, SHINVA showcased comprehensive international solutions for pharmaceutical manufacturing. Leveraging cutting-edge technologies and full-industry-chain capabilities, the company demonstrated the benchmark strength of intelligent Chinese medical manufacturing to Southeast Asian and global markets.
At this year’s CPHI Thailand exhibition, SHINVA focused on intelligent pharmaceutical manufacturing and standardized sterile production assurance. It showcased flagship products and integrated engineering services tailored to pharmaceutical manufacturers and medical institutions across Southeast Asia, including IV soft bag & plastic bottle production lines, BFS plastic bottle manufacturing systems, and full-range sterile assurance solutions. Thailand’s pharmaceutical market is undergoing rapid expansion. SHINVA has successfully delivered multiple local production lines in the country, including peritoneal dialysis fluid production lines, plastic bottle filling lines, BFS manufacturing lines, and fully automatic intelligent inspection equipment.
Boasting one of the world’s fastest-growing pharmaceutical sectors, Thailand stands as a core strategic market under SHINVA global development blueprint. Supported by overseas operation hubs and a mature global distribution network, the company continuously advances its integrated development model of “Products + Services + Localization”, achieving stable project delivery and earning an outstanding reputation in the pharmaceutical equipment sector. This exhibition marks SHINVA in-depth cultivation of the ASEAN market. With an open and cooperative mindset, the enterprise partners with regional stakeholders to build a secure, efficient and sustainable global pharmaceutical industrial chain.
From Made in China to Intelligent Manufacturing in China, from domestic industry leader to globally distributed enterprise, SHINVA Medical adheres to its corporate vision: “To build a world-class enterprise and become a respected innovation leader in healthcare”. Driven by technological breakthroughs, the company fuels industrial upgrading and wins worldwide trust through premium quality and all-round services.
Moving forward, SHINVA Medical will persist in technological innovation, jointly draw cooperation roadmaps with ASEAN partners, and share the booming dividends of the ASEAN pharmaceutical industry. Committed to safeguarding human life with innovative medical technologies and operating globally with integrity, SHINVA Medical will work alongside partners worldwide to embrace a brilliant global future.
